Immunosuppression and Long-term Survival After Single Living-donor Lobar Lung Transplantation From the Same Donor as Prior Hematopoietic Stem Cell Transplantation: An All-Japan Study.
BACKGROUND Single living-donor lobar lung transplantation (LDLLT) from the same donor as prior hematopoietic stem cell transplantation (HSCT) represents a unique immunologic setting because of donor-cell chimerism. However, data regarding immunosuppressive management and long-term outcomes in this setting remain limite...